한중일 경혈점위치 통일회의- 정규한의대 국내수업과정 www.scukorea.com

[예진ㅇㅏ쓰1]

 WHO에서 경혈점을 인정한다는 뜻인지..확실하지는 않지만.

앞으로 연구 과제일듯.---저는 경혈점을 부정하는 입장이지만...

일단 세계보건기구에서 인정했다는 뜻인지..아니면 단지 세계보건기구
아태지역에서 개최한 회의인지부터 확인을 해야 할듯 합니다만.

참고 사항으로..

경혈점이 나라마다 다르다.....
하여튼 아래 자료는 한의학에 유리하게도 불리하게도 볼수 있는 기사일듯 합니다.

과학적 방법론의 원칙대로..불리하든..유리하든 모든 증거를 증명의 근거로
해야 한다는 원칙대로....경혈을 부정하지만...
소개합니다.

한중일의 경혈위치 통일

한중일 3개국에서 미묘한 차이가 있는 침, 뜸 등의 치료에 사용되는 경혈의 위치가 이바라키현 츠쿠바시에서 31일부터 시작된 세계보건기구(WHO)의 「경혈부위 국제표준화 공식회의」에서 통일된다. 이는 동양의학의 경혈에 대한 국제적 「좌표」를 설정하는 것으로, 경혈의 과학적 해명이나 서양의학과의 통합에 박차가 가해질 것으로 보인다.

WHO 등이 뇌졸중의 후유증이나 기관지 천식 등 47개 질환의 치료에 침치료가 효과적이라고 보고 조사한 결과, 합계 361개의 경혈 중 약 1/4에 해당하는 92개의 위치에 차이가 있었다.

예를 들면, 고관절의 아픔을 완화하는 「환도(環跳)」는 허벅지 밑과 엉덩이로 나뉘고 있었다. 또, 위장의 기능을 정돈하는 무릎밑의 경혈인 「족삼리(足三里)」는 한중일 3개국의 차이가 수mm였다.

츠쿠바기술대학 보건과학부의 카타이슈이치(形井秀一) 교수(침구학)에 의하면, 일본은 14세기의 중국고전 「十四經發揮」를 기본으로 경혈을 정해 왔다. 중국은 그 이전의 서적을 근거로 하고 있으며, 한국도 독자적으로 위치를 정해 왔다.

이 때문에, 한중일 3개국 대표가 2003년부터 중국의 고전 「침 구갑을경(鍼灸甲乙經)」(서기 280년) 등을 참고하여 국제표준화의 초안을 협의해 왔다. 약 3년의 격론 끝에 3자가 개략적으로 합의하여 동회의에서 정식 채택되게 되었다.

일본 측 책임자인 카타이 교수는 "침구의료를 보다 발전시키는 좌표가 세계적으로 표준화된다는 점에서 큰 의의가 있다"고 말했다.「침구치료사」, 「마사지 지압사」 등의 국가자격 취득에 필요한 교육이나 시험내용도 변경될 가능성이 있다. 세계 공통의 임상데이터가 모이면, 침구의 치료효과를 입증할 수 있으며, 서양의학의 지식과 조합하여 경혈의 과학적 해명이 진행될 것으로 보인다.

분야명 의학
정보출처 (http://headlines.yahoo.co.jp/hl?a=20061031-00000021-mai-soci)
발행일 2006/10/31
발행국가 JAPAN
원문언어 Japanese
등록일 2006/11/02
원본파일


Traditional medicine

What is traditional medicine?

Traditional medicine refers to health practices, approaches, knowledge and beliefs incorporating plant, animal and m ineral based medicines, spiritual therapies, manual techniques and exercises, applied singularly or in combination to treat, diagnose and prevent illnesses or maintain well-being.

Countries in Africa, Asia and Latin America use traditional medicine (TM) to help meet some of their primary health care needs. In Africa, up to 80% of the population uses traditional medicine for primary health care. In industralized countries, adaptations of traditional medicine are termed “Complementary“ or “Alternative” (CAM).

Increasing use and popularity

TM has maintained its popularity in all regions of the developing world and its use is rapidly spreading in industrialized countries.

In China, traditional herbal preparations account for 30%-50% of the total medicinal consumption.
In Ghana, Mali, Nigeria and Zambia, the first line of treatment for 60% of children with high fever resulting from malaria is the use of herbal medicines at home.
WHO estimates that in several African countrie s traditional birth attendants assist in the majority of births.
In Europe, North America and other industrialized regions, over 50% of the population have used complementary or alternative medicine at least once.
In San Francisco, London and South Africa, 75% of people living with HIV/AIDS use TM/CAM.
70% of the population in Canada have used complementary medicine at least once.
In Germany, 90% of the population have used a natural remedy at some point in their life. Between 1995 and 2000, the number of doctors who had undergone special training in natural remedy medicine had almost doubled to 10 800.
In the United States, 158 million of the adult population use complementary medicines and according to the USA Commission for Alternative and Complementary medicines, US $17 billion was spent on traditional remedies in 2000.
In the United Kingdom, annual expenditure on alternative medicine is US$ 230 million.
The global market for herbal medicines currently stands at over US $ 60 bi llion annually and is growing steadily.
Safety and efficacy issues

Scientific evidence from randomized clinical trials is only strong for many uses of acupuncture, some herbal medicines and for some of the manual therapies. Further research is needed to ascertain the efficacy and safety of several other practices and medicinal plants.

Unregulated or inappropriate use of traditional medicines and practices can have negative or dangerous effects.

For instance, the herb “Ma Huang” (Ephedra) is traditionally used in China to treat respiratory congestion. In the United States, the herb was marketed as a dietary aid, whose over dosage led to at least a dozen deaths, heart attacks and strokes.

In Belgium, at least 70 people required renal transplant or dialysis for interstitial fibrosis of the kidney after taking a herbal preparation made from the wrong species of plant as slimming treatment.

Biodiversity and sustainability

In addition to patient safety issues, there i s the risk that a growing herbal market and its great commercial benefit might pose a threat to biodiversity through the over harvesting of the raw material for herbal medicines and other natural health care products. These practices, if not controlled, may lead to the extinction of endangered species and the destruction of natural habitats and resources.

Another related issue is that at present, the requirements for protection provided under international standards for patent law and by most national conventional patent laws are inadequate to protect traditional knowledge and biodiversity.

Tried and tested methods and products

25% of modern medicines are made from plants first used traditionally.
Acupuncture has been proven effective in relieving postoperative pain, nausea during pregnancy, nausea and vomiting resulting from chemotherapy, and dental pain with extremely low side effects. It can also alleviate anxiety, panic disorders and insomnia.
Yoga can reduce asthma attacks wh ile Tai Ji techniques can help the elderly reduce their fear of falls.
TM can also have impact on infectious diseases. For example, the Chinese herbal remedy Artemisia annua, used in China for almost 2000 years has been found to be effective against resistant malaria and could create a breakthrough in preventing almost one million deaths annually, most of them children, from severe malaria.
In South Africa, the Medical Research Council is conducting studies on the efficacy of the plant Sutherlandia Microphylla in treating AIDS patients. Traditionally used as a tonic, this plant may increase energy, appetite and body mass in people living with HIV.
WHO efforts in promoting safe, effective and affordable traditional medicine

The World Health Organization launched its first ever comprehensive traditional medicine strategy in 2002. The strategy is designed to assist countries to:

Develop national policies on the eval‎uation and regulation of TM/CAM practices;
Create a stronger evidenc e base on the safety, efficacy and quality of the TAM/CAM products and practices;
Ensure availability and affordability of TM/CAM including essential herbal medicines;
Promote therapeutically sound use of TM/CAM by providers and consumers;
Document traditional medicines and remedies.
At present, WHO is supporting clinical studies on antimalarials in three African countries; the studies are revealing good potential for herbal antimalarials.

Other collaboration is taking place with Burkina Faso, the Democratic Republic of the Congo, Ghana, Mali, Nigeria, Kenya, Uganda, and Zimbabwe in the research and eval‎uation of herbal treatments for HIV/ AIDS, malaria, sickle cell anaemia and Diabetes Mellitus.

In Tanzania, WHO, in collaboration with China, is providing technical support to the government for the production of antimalarials derived from the Chinese herb Artemisia annua. Local production of the medicine will bring the price of one dose down from US $6 or $7 to a more affordable $2.

In 2003, WHO support has so far facilitated the development and introduction of traditional and alternative health care curricula in seven tertiary education institutions in the Philippines.

Training workshops on the use of traditional medicines for selected diseases and disorders have also been organized in China, Mongolia and Vietnam.

Priorities for promoting the use of traditional medicines

Over one-third of the population in developing countries lack access to essential medicines. The provision of safe and effective TM/CAM therapies could become a critical tool to increase access to health care.

While China, the Democratic People’s Republic of Korea, the Republic of Korea and Vietnam have fully integrated traditional medicine into their health care systems, many countries are yet to collect and integrate standardized evidence on this type of health care.

70 countries have a national regulation on herbal medicines but the legislative control of medicinal plant s has not evolved around a structured model. This is because medicinal products or herbs are defined differently in different countries and diverse approaches have been adopted with regard to licensing, dispensing, manufacturing and trading.

The limited scientific evidence about TM/CAM’s safety and efficacy as well as other considerations make it important for governments to:

Formulate national policy and regulation for the proper use of TM/CAM and its integration into national health care systems in line with the provisions of the WHO strategies on Traditional Medicines;
Establish regulatory mechanisms to control the safety and quality of products and of TM/CAM practice;
Create awareness about safe and effective TM/CAM therapies among the public and consumers;
Cultivate and conserve medicinal plants to ensure their sustainable use.

For more information contact:


Ms Daniela Bagozzi
Telephone: +41 22 791 4544
Mobile phone: +41 79 475 5490
E-mail: bagozzid@who.int

WHO Media centre
Telephone: +41 22 791 2222
E-mail: mediainquiries@who.int
--------------------------------------------------------------------
http://www.who.int/mediacentre/factsheets/fs134/en/

한국을 사랑하시죠. 요즘은 인터넷시대라 세상이 좁아졌습니다. 일주일에 한번 씩 아메리카 대륙에서 비행기 타고 한국 서울에 와서 일보고 왕복하는 분들이 참 많습니다. 좀은 땅에서 고민할 것이 아니라 넒고 탁 트인 아메리카 대륙에서 호연지기를 기르며 세상을 호령하면서 살 수 있는 직업을 선택하십시오. < 미래 상담 02-741-2526>